Treatment of Skin Fibrosis Market, Global Outlook and Forecast 2022-2028

April 2022 | 61 pages | ID: T874BFF306E8EN
Market Monitor Global

Abstracts

It refers to the treatment of skin myelofibrosis by drugs such as corticosteroids, anti-fibrotic drugs, and immunotherapy drugs.

This report contains market size and forecasts of Treatment of Skin Fibrosis in Global, including the following market information:

Global Treatment of Skin Fibrosis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Treatment of Skin Fibrosis market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Corticosteroids Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Treatment of Skin Fibrosis include Pfizer, Sanofi, F. Hoffmann-La Roche, Boehringer Ingelheim, Jubilant Cadista, Horizon Pharma USA and Bristol-Myers Squibb Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Treatment of Skin Fibrosis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Treatment of Skin Fibrosis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Treatment of Skin Fibrosis Market Segment Percentages, by Type, 2021 (%)

• Corticosteroids
• Antifibrotic Drugs
• Immunotherapy Drugs
• Other

Global Treatment of Skin Fibrosis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Treatment of Skin Fibrosis Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacy
• Retail Pharmacy
• Other

Global Treatment of Skin Fibrosis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Treatment of Skin Fibrosis Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Treatment of Skin Fibrosis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Treatment of Skin Fibrosis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Sanofi
• F. Hoffmann-La Roche
• Boehringer Ingelheim
• Jubilant Cadista
• Horizon Pharma USA
• Bristol-Myers Squibb Company

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Treatment of Skin Fibrosis Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Treatment of Skin Fibrosis Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TREATMENT OF SKIN FIBROSIS OVERALL MARKET SIZE

2.1 Global Treatment of Skin Fibrosis Market Size: 2021 VS 2028
2.2 Global Treatment of Skin Fibrosis Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Treatment of Skin Fibrosis Players in Global Market
3.2 Top Global Treatment of Skin Fibrosis Companies Ranked by Revenue
3.3 Global Treatment of Skin Fibrosis Revenue by Companies
3.4 Top 3 and Top 5 Treatment of Skin Fibrosis Companies in Global Market, by Revenue in 2021
3.5 Global Companies Treatment of Skin Fibrosis Product Type
3.6 Tier 1, Tier 2 and Tier 3 Treatment of Skin Fibrosis Players in Global Market
  3.6.1 List of Global Tier 1 Treatment of Skin Fibrosis Companies
  3.6.2 List of Global Tier 2 and Tier 3 Treatment of Skin Fibrosis Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Treatment of Skin Fibrosis Market Size Markets, 2021 & 2028
  4.1.2 Corticosteroids
  4.1.3 Antifibrotic Drugs
  4.1.4 Immunotherapy Drugs
  4.1.5 Other
4.2 By Type - Global Treatment of Skin Fibrosis Revenue & Forecasts
  4.2.1 By Type - Global Treatment of Skin Fibrosis Revenue, 2017-2022
  4.2.2 By Type - Global Treatment of Skin Fibrosis Revenue, 2023-2028
  4.2.3 By Type - Global Treatment of Skin Fibrosis Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Treatment of Skin Fibrosis Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacy
  5.1.3 Retail Pharmacy
  5.1.4 Other
5.2 By Application - Global Treatment of Skin Fibrosis Revenue & Forecasts
  5.2.1 By Application - Global Treatment of Skin Fibrosis Revenue, 2017-2022
  5.2.2 By Application - Global Treatment of Skin Fibrosis Revenue, 2023-2028
  5.2.3 By Application - Global Treatment of Skin Fibrosis Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Treatment of Skin Fibrosis Market Size, 2021 & 2028
6.2 By Region - Global Treatment of Skin Fibrosis Revenue & Forecasts
  6.2.1 By Region - Global Treatment of Skin Fibrosis Revenue, 2017-2022
  6.2.2 By Region - Global Treatment of Skin Fibrosis Revenue, 2023-2028
  6.2.3 By Region - Global Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Treatment of Skin Fibrosis Revenue, 2017-2028
  6.3.2 US Treatment of Skin Fibrosis Market Size, 2017-2028
  6.3.3 Canada Treatment of Skin Fibrosis Market Size, 2017-2028
  6.3.4 Mexico Treatment of Skin Fibrosis Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Treatment of Skin Fibrosis Revenue, 2017-2028
  6.4.2 Germany Treatment of Skin Fibrosis Market Size, 2017-2028
  6.4.3 France Treatment of Skin Fibrosis Market Size, 2017-2028
  6.4.4 U.K. Treatment of Skin Fibrosis Market Size, 2017-2028
  6.4.5 Italy Treatment of Skin Fibrosis Market Size, 2017-2028
  6.4.6 Russia Treatment of Skin Fibrosis Market Size, 2017-2028
  6.4.7 Nordic Countries Treatment of Skin Fibrosis Market Size, 2017-2028
  6.4.8 Benelux Treatment of Skin Fibrosis Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Treatment of Skin Fibrosis Revenue, 2017-2028
  6.5.2 China Treatment of Skin Fibrosis Market Size, 2017-2028
  6.5.3 Japan Treatment of Skin Fibrosis Market Size, 2017-2028
  6.5.4 South Korea Treatment of Skin Fibrosis Market Size, 2017-2028
  6.5.5 Southeast Asia Treatment of Skin Fibrosis Market Size, 2017-2028
  6.5.6 India Treatment of Skin Fibrosis Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Treatment of Skin Fibrosis Revenue, 2017-2028
  6.6.2 Brazil Treatment of Skin Fibrosis Market Size, 2017-2028
  6.6.3 Argentina Treatment of Skin Fibrosis Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Treatment of Skin Fibrosis Revenue, 2017-2028
  6.7.2 Turkey Treatment of Skin Fibrosis Market Size, 2017-2028
  6.7.3 Israel Treatment of Skin Fibrosis Market Size, 2017-2028
  6.7.4 Saudi Arabia Treatment of Skin Fibrosis Market Size, 2017-2028
  6.7.5 UAE Treatment of Skin Fibrosis Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Treatment of Skin Fibrosis Major Product Offerings
  7.1.4 Pfizer Treatment of Skin Fibrosis Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Sanofi
  7.2.1 Sanofi Corporate Summary
  7.2.2 Sanofi Business Overview
  7.2.3 Sanofi Treatment of Skin Fibrosis Major Product Offerings
  7.2.4 Sanofi Treatment of Skin Fibrosis Revenue in Global Market (2017-2022)
  7.2.5 Sanofi Key News
7.3 F. Hoffmann-La Roche
  7.3.1 F. Hoffmann-La Roche Corporate Summary
  7.3.2 F. Hoffmann-La Roche Business Overview
  7.3.3 F. Hoffmann-La Roche Treatment of Skin Fibrosis Major Product Offerings
  7.3.4 F. Hoffmann-La Roche Treatment of Skin Fibrosis Revenue in Global Market (2017-2022)
  7.3.5 F. Hoffmann-La Roche Key News
7.4 Boehringer Ingelheim
  7.4.1 Boehringer Ingelheim Corporate Summary
  7.4.2 Boehringer Ingelheim Business Overview
  7.4.3 Boehringer Ingelheim Treatment of Skin Fibrosis Major Product Offerings
  7.4.4 Boehringer Ingelheim Treatment of Skin Fibrosis Revenue in Global Market (2017-2022)
  7.4.5 Boehringer Ingelheim Key News
7.5 Jubilant Cadista
  7.5.1 Jubilant Cadista Corporate Summary
  7.5.2 Jubilant Cadista Business Overview
  7.5.3 Jubilant Cadista Treatment of Skin Fibrosis Major Product Offerings
  7.5.4 Jubilant Cadista Treatment of Skin Fibrosis Revenue in Global Market (2017-2022)
  7.5.5 Jubilant Cadista Key News
7.6 Horizon Pharma USA
  7.6.1 Horizon Pharma USA Corporate Summary
  7.6.2 Horizon Pharma USA Business Overview
  7.6.3 Horizon Pharma USA Treatment of Skin Fibrosis Major Product Offerings
  7.6.4 Horizon Pharma USA Treatment of Skin Fibrosis Revenue in Global Market (2017-2022)
  7.6.5 Horizon Pharma USA Key News
7.7 Bristol-Myers Squibb Company
  7.7.1 Bristol-Myers Squibb Company Corporate Summary
  7.7.2 Bristol-Myers Squibb Company Business Overview
  7.7.3 Bristol-Myers Squibb Company Treatment of Skin Fibrosis Major Product Offerings
  7.7.4 Bristol-Myers Squibb Company Treatment of Skin Fibrosis Revenue in Global Market (2017-2022)
  7.7.5 Bristol-Myers Squibb Company Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Treatment of Skin Fibrosis Market Opportunities & Trends in Global Market
Table 2. Treatment of Skin Fibrosis Market Drivers in Global Market
Table 3. Treatment of Skin Fibrosis Market Restraints in Global Market
Table 4. Key Players of Treatment of Skin Fibrosis in Global Market
Table 5. Top Treatment of Skin Fibrosis Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Treatment of Skin Fibrosis Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Treatment of Skin Fibrosis Revenue Share by Companies, 2017-2022
Table 8. Global Companies Treatment of Skin Fibrosis Product Type
Table 9. List of Global Tier 1 Treatment of Skin Fibrosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Treatment of Skin Fibrosis Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Treatment of Skin Fibrosis Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Treatment of Skin Fibrosis Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Treatment of Skin Fibrosis Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Treatment of Skin Fibrosis Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Treatment of Skin Fibrosis Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Treatment of Skin Fibrosis Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Treatment of Skin Fibrosis Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Treatment of Skin Fibrosis Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Treatment of Skin Fibrosis Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Treatment of Skin Fibrosis Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Treatment of Skin Fibrosis Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Treatment of Skin Fibrosis Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Treatment of Skin Fibrosis Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Treatment of Skin Fibrosis Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Treatment of Skin Fibrosis Product Offerings
Table 32. Pfizer Treatment of Skin Fibrosis Revenue (US$, Mn), (2017-2022)
Table 33. Sanofi Corporate Summary
Table 34. Sanofi Treatment of Skin Fibrosis Product Offerings
Table 35. Sanofi Treatment of Skin Fibrosis Revenue (US$, Mn), (2017-2022)
Table 36. F. Hoffmann-La Roche Corporate Summary
Table 37. F. Hoffmann-La Roche Treatment of Skin Fibrosis Product Offerings
Table 38. F. Hoffmann-La Roche Treatment of Skin Fibrosis Revenue (US$, Mn), (2017-2022)
Table 39. Boehringer Ingelheim Corporate Summary
Table 40. Boehringer Ingelheim Treatment of Skin Fibrosis Product Offerings
Table 41. Boehringer Ingelheim Treatment of Skin Fibrosis Revenue (US$, Mn), (2017-2022)
Table 42. Jubilant Cadista Corporate Summary
Table 43. Jubilant Cadista Treatment of Skin Fibrosis Product Offerings
Table 44. Jubilant Cadista Treatment of Skin Fibrosis Revenue (US$, Mn), (2017-2022)
Table 45. Horizon Pharma USA Corporate Summary
Table 46. Horizon Pharma USA Treatment of Skin Fibrosis Product Offerings
Table 47. Horizon Pharma USA Treatment of Skin Fibrosis Revenue (US$, Mn), (2017-2022)
Table 48. Bristol-Myers Squibb Company Corporate Summary
Table 49. Bristol-Myers Squibb Company Treatment of Skin Fibrosis Product Offerings
Table 50. Bristol-Myers Squibb Company Treatment of Skin Fibrosis Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Treatment of Skin Fibrosis Segment by Type in 2021
Figure 2. Treatment of Skin Fibrosis Segment by Application in 2021
Figure 3. Global Treatment of Skin Fibrosis Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Treatment of Skin Fibrosis Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Treatment of Skin Fibrosis Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Treatment of Skin Fibrosis Revenue in 2021
Figure 8. By Type - Global Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 9. By Application - Global Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 10. By Region - Global Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 11. By Country - North America Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 12. US Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 16. Germany Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 17. France Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 24. China Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 28. India Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 30. Brazil Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Treatment of Skin Fibrosis Revenue Market Share, 2017-2028
Figure 33. Turkey Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Treatment of Skin Fibrosis Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Treatment of Skin Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Sanofi Treatment of Skin Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. F. Hoffmann-La Roche Treatment of Skin Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Boehringer Ingelheim Treatment of Skin Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Jubilant Cadista Treatment of Skin Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Horizon Pharma USA Treatment of Skin Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol-Myers Squibb Company Treatment of Skin Fibrosis Revenue Year Over Year Growth (US$, Mn) & (2017-2022)